Colostrum Gold Liquid-Unflavored
100/100
This product looks safe
- No ingredients exceed tolerable upper intake levels
- Limited research evidence available for ingredients
B
Label Compliance Grade
Product Label
Have a supplement label? Find it here.
Upload a photo of any supplement label to search our database of 92,312 products.
Label Data
0.5 Teaspoon(s)
Serving Size
48
Servings
Non-Nutrient/Non-Botanical
Product Type
0%
Evidence Coverage
Supplement Facts — Evidence Check
2.5 Gram(s)
📊 Market median: 800.0mg (172 products)
Other Ingredients
Bovine Colostrum
Label Claims — Verification
❓
All Other
All Other (99% of products)
Structure/Function (84% of products)
Nutrient (26% of products)
No Claim (1% of products)
Target Groups
Adult (18 - 50 Years)
No Allergies
Gluten Free
Sugar Free
Product Information
📋 Directions for Use
Best Used by: August 2012
SUGGESTED USE: 1/2 teaspoon twice daily or as directed by a physician. Dilute in juice, lemonade or other tart liquid.
⚠️ Warnings & Precautions
KEEP OUT OF THE REACH OF CHILDREN.
CONTAINS MILK
🧪 Formulation Notes
FREE OF: Sugar, soy, wheat, casein, gluten, preservatives, yeast, gelatin, flavorings or colorings.
HYPOALLERGENIC
CASEIN & GLUTEN FREE
CONTAINS MILK
Additional Information
IMPORTANT: REFRIGERATE AFTER OPENING.
Colostrum is a natural substance. Color may vary from lot to lot.
(503)694-1600
ULTRA TESTED(TM)
804/4
Product Details
Research Evidence
19
Research Sources
52
Avg Quality Score
8
Clinical Trial
4
Cochrane Review
2
Systematic Review
2
Meta Analysis
2
Guideline
1
Rct
B
[Expert consensus on the application of intravenous immunoglobulin in children with autoimmune neurological disorders (2025)].
B
Executive summary of the KDIGO 2025 Clinical Practice Guideline for the Management of Immunoglobulin A Nephropathy (IgAN) and Immunoglobulin A Vasculitis (IgAV).
B
Pharmacological treatment other than corticosteroids, intravenous immunoglobulin and plasma exchange for Guillain Barré syndrome.
B
Pharmacological treatment other than corticosteroids, intravenous immunoglobulin and plasma exchange for Guillain-Barré syndrome.
B
Pharmacological treatment other than corticosteroids, intravenous immunoglobulin and plasma exchange for Guillain-Barré syndrome.
B
Pharmacological treatment other than corticosteroids, intravenous immunoglobulin and plasma exchange for Guillain-Barré syndrome.
C
Intravenous immunoglobulin for myasthenia gravis
C
Impact of Selenium Supplementation in Neutropenia and Immunoglobulin Production in Childhood Cancer Patients
C
Breast-Milk Iodine Concentrations and Iodine Levels of Infants According to the Iodine Status of the Country of Residence: A Systematic Review and Meta-Analysis
